| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |